mounjaro tirzepatide patent expiration us Republican Administration Maintains Exclusivity Stance in GLP-1 (Tirzepatide) Compounding Dispute Mounjaro Lawsuit - July 2026

Buying based on price alone The cheapest vial on the market is cheap for a reason

Typically, we find that patients taking FDA-approved GLP-1 agonists such as Ozempic and Wegovy will lose 10% of weight by 6 months and 15% within 1 year

Compounded semaglutide offers the same active ingredient at a lower cost

These tests help confirm it is safe for you to start and can identify problems early

The Healthon Weight Loss Program offers two highly effective GLP-1 medications: Semaglutide (Generic Ozempic/Wegovy): A GLP-1 receptor agonist, FDA-approved for weight management and type 2 diabetes

Late responders had lower mean percent weight reduction for each tirzepatide dose compared to early responders at Week 72